| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6182662 | Gynecologic Oncology | 2015 | 7 Pages |
Abstract
The use of metformin in women with T2DM was associated with an overall significantly lower risk of endometrial cancer with dose-response relationship.
Related Topics
Health Sciences
Medicine and Dentistry
Obstetrics, Gynecology and Women's Health
Authors
Chin-Hsiao Tseng,
